International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-2
Original Article
A Review on the Integration of Artificial Intelligence for Clinical and Laboratory Diagnosis
 ,
Published
April 28, 2024
Abstract

Background: The advancement of artificial intelligence (AI) in medicine is associated with applications meant to support physicians in diagnosing patients, selecting treatments, and forecasting their results. Thanks to the quick advancement of analytical tools and the growing availability of healthcare data, it is revolutionizing the healthcare industry. Modern deep learning (DL) and machine learning approaches for structured data, such as neural networks and classical support vector machines, as well as natural language processing for unstructured data, are examples of artificial intelligence techniques. Methodology: More than 60 articles were reviewed, and 45 were selected. The literature review was conducted using the databases PubMed, Embase, Google Scholar, and Scopus. Review: Laboratory medicine uses modern technology to improve clinical decision-making, disease monitoring, and patient safety. Artificial intelligence is increasingly used in clinical microbiology informatics. Genomic data from isolated bacteria, metagenomic microbiological results from original specimens, mass spectra recorded from growing bacterial isolates, and huge digital images are all examples of massive datasets in clinical microbiology that can be used to develop AI diagnoses. Conclusion: Healthcare technological innovation is accelerating and becoming more integrated into our daily lives and medical practices, such as smart health trackers and diagnostic algorithms.

Recommended Articles
Loading Image...
Volume-5, Issue-2
Citations
2649 Views
226 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved